Form 8-K - Current report:
SEC Accession No. 0001140361-24-036283
Filing Date
2024-08-08
Accepted
2024-08-08 07:21:04
Documents
16
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20033789_8k.htm   iXBRL 8-K 33942
2 EXHIBIT 99.1 ef20033789-ex99-1.htm EX-99.1 257522
6 image00001.jpg GRAPHIC 6221
7 image00005.jpg GRAPHIC 3267
  Complete submission text file 0001140361-24-036283.txt   469992

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20240808.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20240808_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20240808_pre.xml EX-101.PRE 16050
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20033789_8k_htm.xml XML 4442
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 241186046
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)